104 related articles for article (PubMed ID: 23902885)
21. Early responses assessment of neoadjuvant chemotherapy in nasopharyngeal carcinoma by serial dynamic contrast-enhanced MR imaging.
Zheng D; Yue Q; Ren W; Liu M; Zhang X; Lin H; Lai G; Chen W; Chan Q; Chen Y
Magn Reson Imaging; 2017 Jan; 35():125-131. PubMed ID: 27587228
[TBL] [Abstract][Full Text] [Related]
22. Value of contrast-enhanced MRI in the differentiation between nasopharyngeal lymphoid hyperplasia and T1 stage nasopharyngeal carcinoma.
Wang ML; Wei XE; Yu MM; Li WB
Radiol Med; 2017 Oct; 122(10):743-751. PubMed ID: 28647899
[TBL] [Abstract][Full Text] [Related]
23. Use of texture analysis based on contrast-enhanced MRI to predict treatment response to chemoradiotherapy in nasopharyngeal carcinoma.
Liu J; Mao Y; Li Z; Zhang D; Zhang Z; Hao S; Li B
J Magn Reson Imaging; 2016 Aug; 44(2):445-55. PubMed ID: 26778191
[TBL] [Abstract][Full Text] [Related]
24. The Value of Tumor Diameter in Predicting Prognosis of Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy.
Niu ZJ; Li T; Liang ZG; Chen XQ; Zhao W; Zhu XD
Otolaryngol Head Neck Surg; 2017 Feb; 156(2):305-311. PubMed ID: 28145845
[TBL] [Abstract][Full Text] [Related]
25. Comparison of SPECT/CT, MRI and CT in diagnosis of skull base bone invasion in nasopharyngeal carcinoma.
Zhang SX; Han PH; Zhang GQ; Wang RH; Ge YB; Ren ZG; Li JS; Fu WH
Biomed Mater Eng; 2014; 24(1):1117-24. PubMed ID: 24212004
[TBL] [Abstract][Full Text] [Related]
26. Nasopharyngeal carcinoma with paranasal sinus invasion: the prognostic significance and the evidence-based study basis of its T-staging category according to the AJCC staging system.
Tian L; Li YZ; Mo YX; Liu LZ; Xie CM; Liang XX; Gong X; Fan W
BMC Cancer; 2014 Nov; 14():832. PubMed ID: 25403714
[TBL] [Abstract][Full Text] [Related]
27. Detection of Local Tumor Recurrence After Definitive Treatment of Head and Neck Squamous Cell Carcinoma: Histogram Analysis of Dynamic Contrast-Enhanced T1-Weighted Perfusion MRI.
Choi SH; Lee JH; Choi YJ; Park JE; Sung YS; Kim N; Baek JH
AJR Am J Roentgenol; 2017 Jan; 208(1):42-47. PubMed ID: 27680294
[TBL] [Abstract][Full Text] [Related]
28. Magnetic Resonance Imaging-Detected Intracranial Extension in the T4 Classification Nasopharyngeal Carcinoma with Intensity-Modulated Radiotherapy.
Cao C; Luo J; Gao L; Yi J; Huang X; Li S; Xiao J; Zhang Z; Xu G
Cancer Res Treat; 2017 Apr; 49(2):518-525. PubMed ID: 27554478
[TBL] [Abstract][Full Text] [Related]
29. Should all nasopharyngeal carcinoma with masticator space involvement be staged as T4?
Sze H; Chan LL; Ng WT; Hung AW; Lee MC; Chang AT; Chan OS; Cheung FY; Yeung RM; Lee AW
Oral Oncol; 2014 Dec; 50(12):1188-95. PubMed ID: 25261296
[TBL] [Abstract][Full Text] [Related]
30. [Role of 18F-FDG PET/CT in diagnosis and staging of nasopharyngeal carcinoma].
Lin XP; Zhao C; Chen MY; Fan W; Zhang X; Zhi SF; Liang PY
Ai Zheng; 2008 Sep; 27(9):974-8. PubMed ID: 18799039
[TBL] [Abstract][Full Text] [Related]
31. Early response to chemoradiotherapy for nasopharyngeal carcinoma treatment: Value of dynamic contrast-enhanced 3.0 T MRI.
Zheng D; Chen Y; Liu X; Chen Y; Xu L; Ren W; Chen W; Chan Q
J Magn Reson Imaging; 2015 Jun; 41(6):1528-40. PubMed ID: 25136770
[TBL] [Abstract][Full Text] [Related]
32. Quantitative dynamic contrast-enhanced and diffusion-weighted MRI for differentiation between nasopharyngeal carcinoma and lymphoma at the primary site.
Yu XP; Hou J; Li FP; Xiang W; Lu Q; Hu Y; Wang H
Dentomaxillofac Radiol; 2016; 45(3):20150317. PubMed ID: 26846711
[TBL] [Abstract][Full Text] [Related]
33. Staging and follow-up of nasopharyngeal carcinoma: magnetic resonance imaging versus computerized tomography.
Olmi P; Fallai C; Colagrande S; Giannardi G
Int J Radiat Oncol Biol Phys; 1995 Jun; 32(3):795-800. PubMed ID: 7790266
[TBL] [Abstract][Full Text] [Related]
34. Assessment of coronary microvascular dysfunction in hypertrophic cardiomyopathy: first-pass myocardial perfusion cardiovascular magnetic resonance imaging at 1.5 T.
Huang L; Han R; Ai T; Sun Z; Bai Y; Cao Z; Morelli JN; Xia L
Clin Radiol; 2013 Jul; 68(7):676-82. PubMed ID: 23566329
[TBL] [Abstract][Full Text] [Related]
35. Pretreatment MR imaging radiomics signatures for response prediction to induction chemotherapy in patients with nasopharyngeal carcinoma.
Wang G; He L; Yuan C; Huang Y; Liu Z; Liang C
Eur J Radiol; 2018 Jan; 98():100-106. PubMed ID: 29279146
[TBL] [Abstract][Full Text] [Related]
36. Assessment of dynamic contrast-enhanced magnetic resonance imaging in the differentiation of malignant from benign orbital masses.
Yuan Y; Kuai XP; Chen XS; Tao XF
Eur J Radiol; 2013 Sep; 82(9):1506-11. PubMed ID: 23561057
[TBL] [Abstract][Full Text] [Related]
37. DCE-MRI assessment of the effect of Epstein-Barr virus-encoded latent membrane protein-1 targeted DNAzyme on tumor vasculature in patients with nasopharyngeal carcinomas.
Liao WH; Yang LF; Liu XY; Zhou GF; Jiang WZ; Hou BL; Sun LQ; Cao Y; Wang XY
BMC Cancer; 2014 Nov; 14():835. PubMed ID: 25407966
[TBL] [Abstract][Full Text] [Related]
38. Investigation of the feasibility of synthetic MRI in the differential diagnosis of non-keratinising nasopharyngeal carcinoma and benign hyperplasia using different contoured methods for delineation of the region of interest.
Meng T; He H; Liu H; Lv X; Huang C; Zhong L; Liu K; Qian L; Ke L; Xie C
Clin Radiol; 2021 Mar; 76(3):238.e9-238.e15. PubMed ID: 33213835
[TBL] [Abstract][Full Text] [Related]
39. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
[TBL] [Abstract][Full Text] [Related]
40. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity-modulated radiotherapy.
Pan JJ; Ng WT; Zong JF; Chan LL; O'Sullivan B; Lin SJ; Sze HC; Chen YB; Choi HC; Guo QJ; Kan WK; Xiao YP; Wei X; Le QT; Glastonbury CM; Colevas AD; Weber RS; Shah JP; Lee AW
Cancer; 2016 Feb; 122(4):546-58. PubMed ID: 26588425
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
